 "Transferra Nanosciences and Evonik officials signing the pact")
German specialty chemicals company Evonik has acquired Transferra Nanosciences Inc (formerly known as Northern Lipids Inc), a biotechnology company based in Burnaby close to Vancouver (Canada), for an undisclosed price.
Transferra is a contract development and manufacturing organisation (CDMO) that provides services as well as products to biotechnology companies engaged in the development of pharmaceutical products, using the company’s unique expertise in liposomal drug delivery systems. The acquisition allows Evonik to further expand the portfolio of its heathcare business line in the area of parenteral drug delivery technologies and services.
“This transaction reflects our continued commitment to growth in the healthcare area and in the drug delivery space in particular,” said Dr Reiner Beste, chairman of the Board of Management of Evonik Nutrition & Care GmbH.
Transferra services include prototype identification, scale-up and process development, analytical support and qualification of methods, production of test articles for toxicology studies and cGMP manufacturing of clinical trial materials. In addition Transferra offers a range of benchtop LIPEX extruders, as well as custom-built LIPEX extruders for large scale manufacture of commercial drug products.
